期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 139, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejps.2019.105063
关键词
Proticles; PEGylation; SPECT imaging; in vivo pharmacokinetics
资金
- Austrian Nano-Initiative [0200]
- Austrian FWF (Fonds zur Forderung der Wissenschaftlichen Forschung) [N208-NAN, N203-NAN]
- Tiroler Wissenschaftsfond [UNI-0404/417]
The development of so-called Proticles opens attractive possibilities for new drug delivery systems. Proticles are nanoparticles (NPs), which are formed by self-assembly of negatively charged oligonucleotides in combination with the positively charged peptide protamine. Polyethylene glycol (PEG) is a widely known pharmaceutical agent to stop particle growth and prolong circulation half-life of drug delivery systems. Therefore, two different NP formulations - one PEGylated and one non-PEGylated - were used in this work to gain information about the biological stability and half-life in circulation of Proticles. Thus, this study presents data of in vitro stability and in vivo pharmacokinetics of both, non-PEGylated and PEGylated Proticles radiolabeled with (InCl3)-In-111. The study demonstrated that successful radiolabeling of both Proticle-formulations was performed resulting in high radiochemical yields (> 85 %). Furthermore, the influence of PEGylation on the in vitro stability of (111)Inradiolabeled NPs was investigated. No significant difference due to PEGylation was found. Unlike in vitro results, non-PEGylated In-111-Proticles seemed to degrade faster in vivo than PEGylated In-111-proticles, resulting in significantly higher blood values (In-111-PEG-proticles: 0.23 +/- 0.01 % ID/g 1 h p.i.; In-111-proticles: 0.06 +/- 0.01 % ID/g 1 h p.i.; p < 0.05). Visualized by SPECT imaging urinary excretion represented the major pathway of elimination for both NP-formulations. In conclusion, this study provides data indicating a positive influence of PEG-derivatization on the biodistribution and pharmacokinetics of Proticles. These results form the basis for further developments as drug delivery and active drug targeting devices.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据